<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Kite and the CIBMTR® Present Positive Findings From Real-World Use of Yescarta® (Axicabtagene Ciloleucel) in Relapsed or Refractory Large B-Cell Lymphoma	</title>
	<atom:link href="https://www.novumpr.nl/2019/12/09/kite-and-the-cibmtr-present-positive-findings-from-real-world-use-of-yescarta-axicabtagene-ciloleucel-in-relapsed-or-refractory-large-b-cell-lymphoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2019/12/09/kite-and-the-cibmtr-present-positive-findings-from-real-world-use-of-yescarta-axicabtagene-ciloleucel-in-relapsed-or-refractory-large-b-cell-lymphoma/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=kite-and-the-cibmtr-present-positive-findings-from-real-world-use-of-yescarta-axicabtagene-ciloleucel-in-relapsed-or-refractory-large-b-cell-lymphoma</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Mon, 09 Dec 2019 20:09:23 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
